NEW ONCE-DAILY ORAL DIABETES TREATMENT GLUMETZA NOW AVAILABLE

Adult patients living with type 2 diabetes now have a new treatment option available that may help them get the most out of their care. King Pharmaceuticals, Inc. and Depomed, Inc. announced the commercial availability of Glumetza (metformin hydrochloride extended release tablets) in the United States. Glumetza, an oral treatment for type 2 diabetes, offers the benefits of metformin, including reliable glycemic control, absence of weight gain, and a low incidence of hypoglycemia, with the added convenience of once-daily dosing.
Genetic Engineering News